Company Filing History:
Years Active: 2016
Title: Shi-Wen Luo: Innovator in ERBB2 Conjugate Peptides
Introduction
Shi-Wen Luo is a notable inventor based in Augusta, GA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods involving ERBB2 conjugate peptides. His work focuses on compositions that inhibit or block the interaction between Erbin and ErbB2, which has important implications for therapeutic applications.
Latest Patents
Shi-Wen Luo holds 1 patent for his invention titled "Methods of using ERBB2 conjugate peptides." This patent describes compositions that inhibit or block the interaction between Erbin and ErbB2. The preferred compositions include peptides that function effectively under physiologic conditions in a subject. One embodiment of his invention provides an isolated peptide fragment of ErbB2, which includes the C-terminal 15 amino acids of ErbB2. The peptide fragment can vary in length from about 15 to 27 amino acids.
Career Highlights
Shi-Wen Luo is affiliated with the Augusta University Research Institute, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Shi-Wen Luo collaborates with esteemed colleagues, including Lin Mei and Wen-Cheng Xiong, who contribute to his research endeavors.
Conclusion
Shi-Wen Luo's innovative work in the field of ERBB2 conjugate peptides showcases his commitment to advancing biotechnology. His contributions have the potential to impact therapeutic strategies significantly.